Moderna CEO Plans Cancer Shot to Address Doubts
Hyperdash NewsEquitiesModerna CEO Stéphane Bancel plans to address company doubters with a new cancer shot. The company is developing a vaccine for cancer, which could become a major revenue driver. This initiative aims to bolster investor confidence and expand Moderna's market presence beyond COVID-19 vaccines.
The company is preparing to file for US approval and expects the cancer vaccine to launch in 2027. This personalized mRNA vaccine, developed with Merck, reduced the risk of melanoma recurrence or death by 42% in a Phase 3 trial. Hyperdash markets have 
Trade these markets 24/7 on Hyperdash
Disclaimer: The content provided on Hyperdash News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of information sourced from third-party reporting. Nothing on this page constitutes financial or investment advice. Do your own research and consult a qualified financial advisor before making any investment decisions.